Comparison of gentamicin dosing regimens using an in-vitro model.

Area of Science:

• Pharmacology
• Microbiology
• Infectious Diseases

Background:

• Gentamicin is a critical antibiotic for treating Pseudomonas aeruginosa infections.
• Optimizing gentamicin dosing regimens is essential to maximize efficacy and minimize resistance.
• Current dosing strategies may not be ideal for achieving sustained bactericidal effects.

Purpose of the Study:

• To compare the efficacy of different gentamicin dosing regimens against Pseudomonas aeruginosa using an in-vitro pharmacokinetic model.
• To evaluate the impact of peak and trough concentrations on bacterial killing and regrowth.
• To determine if current gentamicin dosing recommendations are optimal.

Main Methods:

• Utilized an in-vitro model simulating in-vivo pharmacokinetics.
• Compared various gentamicin dosing regimens with identical total daily doses but different peak/trough concentrations.
• Assessed bactericidal effect, bacterial regrowth, and post-antibiotic effect.

Main Results:

• Initial gentamicin exposure demonstrated rapid, peak concentration-dependent bactericidal effects.
• Subsequent doses showed diminished bactericidal activity, with bacterial regrowth observed across all regimens.
• Higher peak concentrations and longer intervals between doses prolonged the time to bacterial regrowth.
• Continuous infusion, despite high concentrations, showed an inhibitory effect but still permitted regrowth.

Conclusions:

• Larger initial bolus doses and extended dosing intervals for gentamicin are supported by this data.
• Current gentamicin dosing recommendations may need revision to improve therapeutic outcomes.
• Optimized dosing can enhance bacterial killing and delay the onset of resistance.